Cipher Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This page contains a zero-cost E,S&G analysis covering Cipher Pharmaceuticals Inc. This assessment of Cipher Pharmaceuticals Inc is assembled by All Street Sevva using cutting edge AI. If you are employed by Cipher Pharmaceuticals Inc and you wish to use your Sustainability rating, please contact us.
Cipher Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Cipher Pharmaceuticals Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cipher Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cipher Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cipher Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cipher Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Cipher Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cipher Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cipher Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.